B3GNT7 Antikörper (Center)
Kurzübersicht für B3GNT7 Antikörper (Center) (ABIN7834713)
Target
Alle B3GNT7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Center
-
Verwendungszweck
- Rabbit polyclonal antibody to B3GNT7
-
Spezifität
- Recognizes endogenous levels of B3GNT7 protein
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the center region of human B3GNT7. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/500 - 1/1000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- B3GNT7 (beta-1,3-N-Acetylglucosaminyltransferase 7 (B3GNT7))
-
Andere Bezeichnung
- B3GNT7
-
Hintergrund
- UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7, BGnT-7, Beta-1,3-Gn-T7, Beta-1,3-N-acetylglucosaminyltransferase 7, Beta3Gn-T7
-
Gen-ID
- 93010, 227327, 316583
-
UniProt
- Q8NFL0
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-